Adenosine signalling in asthma and COPD

R. Polosa (Catania, Italy)

Source: Annual Congress 2011 - Adenosine and purigenic signalling in inflammatory lung disease
Session: Adenosine and purigenic signalling in inflammatory lung disease
Session type: Symposium
Number: 3194
Disease area: Airway diseases

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Polosa (Catania, Italy). Adenosine signalling in asthma and COPD. Annual Congress 2011 - Adenosine and purigenic signalling in inflammatory lung disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Biomarkers in asthma and COPD
Source: Annual Congress 2011 - PG20 Biomarkers in respiratory medicine
Year: 2011


Role of obesity in asthma and COPD
Source: Annual Congress 2011 - PG5 Asthma versus COPD: similarities and differences
Year: 2011


Common genes for asthma and COPD?
Source: Annual Congress 2010 - PG15 Postgraduate Course: Asthma and COPD: similarities and differences
Year: 2010



JAK/STATs in asthma and COPD
Source: Annual Congress 2004 - Transcription factors in airway disease
Year: 2004

Sputum eosinophilia identifies systemic corticosteroid responsiveness in acute exacerbations of COPD
Source: Annual Congress 2011 - Mechanism and monitoring of airway diseases
Year: 2011


Essential role for ATP in the pathogenesis of COPD and emphysema
Source: Annual Congress 2010 - Pre-clinical models of airways disease
Year: 2010

The link between rhinitis, asthma and occupation
Source: Annual Congress 2010 - PG14 Core Curriculum Postgraduate Course: Occupational asthma: risk factors and management
Year: 2010



Chronic rhinosinusitis and airway inflammation in new onset asthma in adults
Source: Annual Congress 2011 - Asthma mechanisms
Year: 2011

Disturbed hypoxic-angiogenic signalling mediating muscle cachexia in COPD
Source: Annual Congress 2010 - New mechanisms in chronic lung diseases
Year: 2010



Differences in responsiveness of airways to AMP and methacholine in asthma and COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 93s
Year: 2001

How to define clinically relevant phenotypes and endotypes of asthma and COPD
Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD
Year: 2011



The study of bronchospastic eicosanoids levels in asthma and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 454s
Year: 2003

COPD: the link between gene-expression and the clinic
Source: Annual Congress 2010 - Phenotypic fingerprinting in asthma and COPD: systems biology is entering the clinic
Year: 2010


Overlapping phenotypes in asthma and COPD
Source: Annual Congress 2010 - Similarities and differences between asthma and COPD: the "Dutch Hypothesis" revisited
Year: 2010